Subbarayudu Putta

Title: Subbarayudu Putta: Innovator in Pharmaceutical Formulations

Introduction

Subbarayudu Putta is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the efficacy of medications. His work is characterized by a focus on innovative processes that improve drug delivery and formulation stability.

Latest Patents

One of Subbarayudu Putta's key patents is titled "Premix of crystalline raltegravir potassium salt and a process for the preparation thereof." This patent outlines a process for preparing a premix of raltegravir potassium form 3 with excipients. The premix is designed for use in the manufacture of pharmaceutical formulations containing raltegravir, a medication used in the treatment of HIV.

Career Highlights

Subbarayudu Putta is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role at Mylan has allowed him to leverage his expertise in pharmaceutical formulations, contributing to the development of innovative products that meet the needs of patients worldwide.

Collaborations

Throughout his career, Subbarayudu has collaborated with several professionals in the industry, including Ramesh Dandala and Sivarama Prasad Vellanki. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical research and development.

Conclusion

Subbarayudu Putta's contributions to the field of pharmaceuticals, particularly through his patent on raltegravir potassium formulations, highlight his role as an innovator in the industry. His work continues to impact the development of effective treatments for patients.